-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I0BOsjE9oikaD2pYEWq2Zxvfiy91Z7I/nIPEzpecXbZwOShXlLMjf62S15t328FR kJ9x//0u9WA97iVJh0rZ6g== 0001193125-10-265831.txt : 20110106 0001193125-10-265831.hdr.sgml : 20110106 20101122090257 ACCESSION NUMBER: 0001193125-10-265831 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12671 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 259-1165 MAIL ADDRESS: STREET 1: 12671 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 CORRESP 1 filename1.htm Acceleration Request - Underwriters

November 22, 2010

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Zogenix, Inc.
   Registration Statement on Form S-1
   File No. 333-169210

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, we hereby join in the request of Zogenix, Inc. (the “Company”) for acceleration of the effective date of the above-referenced registration statement relating to the Company’s offering of shares of its common stock so that such registration statement is declared effective at 5:30 p.m. (Washington, D.C. time) on Monday, November 22, 2010, or as soon as practicable thereafter.

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that the preliminary prospectus dated November 4, 2010 prepared by the Company in connection with the offering referred to above was distributed as follows:

 

     110 copies       to Underwriters   
     3,607 copies       to Institutions   
     2,381 copies       to Others   
              
Total:      5,558 copies         

The undersigned advise you that they have complied with Rule 15c2-8 under the Securities Exchange Act of 1934.

 

Very truly yours,
WELLS FARGO SECURITIES, LLC
By:  

/S/    DAVID HERMAN        

Name:   David Herman
Title:   Director
LEERINK SWANN LLC
By:  

/S/    JOHN I. FITZGERALD        

Name:   John I. Fitzgerald
Title:   Director
As Representative of the several Underwriters
 -----END PRIVACY-ENHANCED MESSAGE-----